and Translation Forum on Drug Discovery, Development

Innovation in Drug Research and Development for Prevalent Chronic Diseases

Proceedings of a Workshop

Avand Medicine National Academies of Sciences, Engineering,Health and Medicine Division m. fl.

Häftad, Engelska, 2021

459 kr

Tillfälligt slut

Adverse Drug Event Reporting

The Roles of Consumers and Health-Care Professionals: Workshop Summary

AvInstitute of Medicine,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2007

449 kr

Tillfälligt slut

Understanding the Benefits and Risks of Pharmaceuticals

Workshop Summary

Avand Translation Forum on Drug Discovery, Development,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2007

449 kr

Tillfälligt slut

Addressing the Barriers to Pediatric Drug Development

Workshop Summary

Avand Translation Forum on Drug Discovery, Development,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2008

449 kr

Tillfälligt slut

Challenges for the FDA

The Future of Drug Safety: Workshop Summary

AvInstitute of Medicine,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2007

679 kr

Tillfälligt slut

Emerging Safety Science

Workshop Summary

AvInstitute of Medicine,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2008

759 kr

Tillfälligt slut

Breakthrough Business Models

Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary

AvInstitute of Medicine,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2009

739 kr

Tillfälligt slut

Accelerating the Development of Biomarkers for Drug Safety

Workshop Summary

Avand Translation Forum on Drug Discovery, Development,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2009

449 kr

Tillfälligt slut

Public Health Emergency Medical Countermeasures Enterprise

Innovative Strategies to Enhance Products from Discovery Through Approval: Workshop Summary

AvInstitute of Medicine,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2010

899 kr

Tillfälligt slut

Transforming Clinical Research in the United States

Challenges and Opportunities: Workshop Summary

AvInstitute of Medicine,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2010

779 kr

Tillfälligt slut

Building a National Framework for the Establishment of Regulatory Science for Drug Development

Workshop Summary

AvBoard on Health Sciences Policy,and Translation Forum on Drug Discovery, Development m. fl.

Häftad, Engelska, 2011

449 kr

Tillfälligt slut

Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa

Global and Local Challenges and Solutions: Summary of a Joint Workshop by the Institute of Medicine and the Academy of Science of South Africa

AvAcademy of Science of South Africa,Institute of Medicine m. fl.

Häftad, Engelska, 2011

729 kr

Tillfälligt slut

Direct-to-Consumer Genetic Testing

Summary of a Workshop

AvNational Research Council,Institute of Medicine m. fl.

Häftad, Engelska, 2010

599 kr

Tillfälligt slut

New Profile of Drug-Resistant Tuberculosis in Russia

A Global and Local Perspective: Summary of a Joint Workshop by the Institute of Medicine and the Russian Academy of Medical Science

AvRussian Academy of Medical Sciences,Institute of Medicine m. fl.

Häftad, Engelska, 2011

589 kr

Tillfälligt slut

Advancing Regulatory Science for Medical Countermeasure Development

Workshop Summary

AvInstitute of Medicine,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2011

699 kr

Tillfälligt slut

Public Engagement and Clinical Trials

New Models and Disruptive Technologies: Workshop Summary

AvInstitute of Medicine,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2012

629 kr

Tillfälligt slut

Facing the Reality of Drug-Resistant Tuberculosis in India

Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research

AvInstitute of Medicine,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2012

789 kr

Tillfälligt slut

Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development

Workshop Summary

AvInstitute of Medicine,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2012

479 kr

Tillfälligt slut

Envisioning a Transformed Clinical Trials Enterprise in the United States

Establishing an Agenda for 2020: Workshop Summary

AvInstitute of Medicine,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2012

759 kr

Tillfälligt slut

Accelerating the Development of New Drugs and Diagnostics

Maximizing the Impact of the Cures Acceleration Network: Workshop Summary

AvInstitute of Medicine,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2012

609 kr

Tillfälligt slut

Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis

Workshop Summary

AvInstitute of Medicine,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2013

699 kr

Tillfälligt slut

Sharing Clinical Research Data

Workshop Summary

AvInstitute of Medicine,Board on Health Care Services m. fl.

Häftad, Engelska, 2013

649 kr

Tillfälligt slut

Envisioning a Transformed Clinical Trials Enterprise for 2030

Proceedings of a Workshop

Avand Medicine National Academies of Sciences, Engineering,Health and Medicine Division m. fl.

Häftad, Engelska, 2022

469 kr

Tillfälligt slut

International Regulatory Harmonization Amid Globalization of Drug Development

Workshop Summary

AvInstitute of Medicine,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2013

609 kr

Tillfälligt slut

Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS

Challenges and Opportunities: Summary of a Joint Workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences

Avand Translation Forum on Drug Discovery, Development,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2014

749 kr

Tillfälligt slut

Large Simple Trials and Knowledge Generation in a Learning Health System

Workshop Summary

AvInstitute of Medicine,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2013

589 kr

Tillfälligt slut

Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products

Workshop Summary

AvInstitute of Medicine,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2014

709 kr

Tillfälligt slut

Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders

Workshop Summary

AvInstitute of Medicine,Board on Health Sciences Policy m. fl.

Häftad, Engelska, 2015

699 kr

Tillfälligt slut

Rapid Medical Countermeasure Response to Infectious Diseases

Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships: Workshop Summary

Avand Medicine National Academies of Sciences, Engineering,Institute of Medicine m. fl.

Häftad, Engelska, 2016

779 kr

Tillfälligt slut

Advancing the Discipline of Regulatory Science for Medical Product Development

An Update on Progress and a Forward-Looking Agenda: Workshop Summary

Avand Medicine National Academies of Sciences, Engineering,Health and Medicine Division m. fl.

Häftad, Engelska, 2016

619 kr

Tillfälligt slut

and Translation Forum on Drug Discovery, Development - Böcker

Innovation in Drug Research and Development for Prevalent Chronic Diseases

Adverse Drug Event Reporting

Understanding the Benefits and Risks of Pharmaceuticals

Addressing the Barriers to Pediatric Drug Development

Challenges for the FDA

Emerging Safety Science

Breakthrough Business Models

Accelerating the Development of Biomarkers for Drug Safety

Public Health Emergency Medical Countermeasures Enterprise

Transforming Clinical Research in the United States

Building a National Framework for the Establishment of Regulatory Science for Drug Development

Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa

Direct-to-Consumer Genetic Testing

New Profile of Drug-Resistant Tuberculosis in Russia

Advancing Regulatory Science for Medical Countermeasure Development

Public Engagement and Clinical Trials

Facing the Reality of Drug-Resistant Tuberculosis in India

Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development

Envisioning a Transformed Clinical Trials Enterprise in the United States

Accelerating the Development of New Drugs and Diagnostics

Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis

Sharing Clinical Research Data

Envisioning a Transformed Clinical Trials Enterprise for 2030

International Regulatory Harmonization Amid Globalization of Drug Development

Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS

Large Simple Trials and Knowledge Generation in a Learning Health System

Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products

Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders

Rapid Medical Countermeasure Response to Infectious Diseases

Advancing the Discipline of Regulatory Science for Medical Product Development